Prof hanan anti phospholipid syndrome with highlights on criteria and seronegative antiphospholipid
Head of internal medicine, faculty of medicine, Beni-Suef University
First lupus day October 2018
Prof hanan anti phospholipid syndrome with highlights on criteria and seronegative antiphospholipid
Head of internal medicine, faculty of medicine, Beni-Suef University
First lupus day October 2018
MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(
An Octogenarian Patient Of Intracapsular Neck Of Femur Fracture With Pre-oper...DrShinyKajal
Pre-operative Thrombocytopenia
collection and preparation of sdp single donor platelets
Hb, pt inr, platelet counts
apheresis
principle
donation criteria
sdp vs rdp
guidelines for platelet transfusion
etiologies of thrombocytopenia
isolated thrombocytopenia management
first line second line management
A case presentation of Exchange Transfusion in new born infant with Neonatal ...DrShinyKajal
A case of Exchange Transfusion in new born infant with Neonatal Jaundice and Rh incompatibility
transfusion management
double volume exchange transfusion
follow up at blood centre
antibody screening
direct antiglobulin test
technique
AABB standards
reconstituted whole blood
hyperbilirubinemia
kernicterus
encephalopathy
hematocrit and volume
Hemolytic disease of the fetus and newborn
Antigens which can cross placenta
RH immunoglobulin administration
RhIg
More Related Content
Similar to Granulocyte antigens & antibodies and their role in transfusion medicinepptx
MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(ISBT001) and RH(ISBT004)MAJOR BLOOD GROUPS, ABO(
An Octogenarian Patient Of Intracapsular Neck Of Femur Fracture With Pre-oper...DrShinyKajal
Pre-operative Thrombocytopenia
collection and preparation of sdp single donor platelets
Hb, pt inr, platelet counts
apheresis
principle
donation criteria
sdp vs rdp
guidelines for platelet transfusion
etiologies of thrombocytopenia
isolated thrombocytopenia management
first line second line management
A case presentation of Exchange Transfusion in new born infant with Neonatal ...DrShinyKajal
A case of Exchange Transfusion in new born infant with Neonatal Jaundice and Rh incompatibility
transfusion management
double volume exchange transfusion
follow up at blood centre
antibody screening
direct antiglobulin test
technique
AABB standards
reconstituted whole blood
hyperbilirubinemia
kernicterus
encephalopathy
hematocrit and volume
Hemolytic disease of the fetus and newborn
Antigens which can cross placenta
RH immunoglobulin administration
RhIg
A Case presentation of Massive Transfusion in post LSCS PPH patientDrShinyKajal
workup at blood centre
components issued
transfusion summary
criteria for massive transfusion
goal of massive transfusion
Indication protocol for massive transfusion for whole blood, prbc, ffp, cryo, platelets
Targets of resuscitation in massive blood loss
Complications of Massive Transfusion
citrate toxicity
lethal triad
case presentation on diagnosis of beta thalassemia majorDrShinyKajal
case history of 9 month old infant
Paediatric Clinical Approach to this case
examination
workup at blood centre
HPLC screening
laboratory findings
screening of father mother
prominent facial features
PBF and bone marrow findings
usg abdomen
xray skull
prbc transfusion therapy in thalassemia major
classification of thalassemia
national burden in india
pathogenesis- anemia skull bone iron overload
world thalassemia day
Troubleshooting in Transfusion transmissible infection TTI laboratoryDrShinyKajal
Checklist of categories for troubleshooting in TTI
Factors affecting Troubleshooting in TTI Lab
controls used in assay testing
Principles and Practices of ELISA and Rapid for TTI Screening
Equipment Management in TTI Laboratory
calibration of equipments used
Documentation and Records in TTI Laboratory
Root Cause Analysis and Process Improvement in TTI Laboratory
External Quality Assessment Scheme and Proficiency Testing
Waste management in transfusion centre
Principle of Troubleshooting in TTI Lab
Case presentation onHeterozygous variant of Hemoglobin EDrShinyKajal
case presentation on heterozygous hemoglobin E
investigations
HPLC high performance liquid chromatography test
HbA2
fetal hemoglobin values in different variants of hempglobin
hemoglobinopathies
HbS, HbE, HbD
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
Blood group antibodies
different reaction grades
test material required for antibody identification
procedure
antibody screening using 2-3 cell panel
antibpdy identification using 11 cell panel
immediate spin phase
37 degree c
ahg phase
check cells
interpretation antibody workups
enzyme technique
Tissue Banking and Umbilical Cord Blood BankingDrShinyKajal
Umbilical cord blood vs bone marrow vs peripheral stem cells
indications of stem cell transplant
Regulatory requirements for cord blood banking
Requirements for processing, testing and storage areas for UCB
Air-handling system
Personnel for Cord Blood Bank
Collection of processed UCB component
procedure- in utero ex utero
transportation
processing
freezing
storage
screening tests
quality control
advantages and disadvantages
labelling
tissue collection
live and deceased donors
Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Tra...DrShinyKajal
AABB indications
Elective surgeries- Maximum surgical blood ordering schedule
Anemia and surgery- including Transfusion Trigger
Surgery and coagulation disorders- including factor replacement
Transfusion in cardiac surgeries- including autologous transfusion
Patient Blood management in surgery
Allogenic Transfusion
Autologous Transfusion- Intra And Postoperative Red Cell Salvage, Haemodilution
Blood Substitutes
Haematopoietic Factors
Antifibrinolytics
Fibrin Sealants
Conjugated Oestrogens.
AABB pretransfusion testing schemes
Type and screen
Maximum surgical blood ordering schedule
transfusion trigger for surgery
factor replacement in surgery
autologous transfusion
cell salvage
perioperative
massive transfusion protocol
pathogen inactivation of cellular components.pptxDrShinyKajal
Chemical inactivation
Photo-inactivation
Solvent-detergent Plasma
Photosensitizers
Methylene Blue light treatment
Psoralen Ultraviolet Light Treatment
Riboflavin Light Treatment
INTERCEPT System
Mirasol system
Platelet and plasma Pathogen Inactivation
FRALE and azridine compounds
1. Bio preservation of Red Cell Components 2. CULTURED RBCs 3. solvent plasmaDrShinyKajal
1. Bio preservation of Red Cell Components
2. CULTURED RBCs
3. Solvent plasma
Hypothermic storage
Cryopreservation
Lyophilization
Desiccated RBCs
Three major sources of cells are under consideration:
circulating stem and progenitor cells from adults or from cord blood
immortalized progenitors
pluripotent stem cells.
Immortalized Progenitors
LIQUID CULTURE METHODS- by the SED (stem cell factor (SCF), erythropoietin, and dexamethasone) and STIF cocktails (stem cell factor, thombopoietin, insulin-like growth factor-2, fibroblast growth factor-2)
ENUCLEATION- separation of extruded nuclei from cRBCs
SCALING UP- using cord blood CD34+ cells in bioreactors
and treated for 4 h with TNBP (tri-nitrobutylphosphate)solvent and with Triton X-100 detergent
Storage of Blood Components- equipments, effects of improper storage, transpo...DrShinyKajal
Introduction
Equipments required
Harmful effects of improper storage
Storage of various blood components- AABB guidelines
NACO guidelines for storage
Storage during transport
Storage in frozen state
Physical and chemical changes in stored blood
Human Stem Cells- Introduction
Types of HSC transplants
Indications
Sources of stem cells
Collection and mobilization
Types of Mobilizing agents
Processing
Cryopreservation and storage
PBSC Transplant
Quality control
Complications
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...kevinkariuki227
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Edition by Donnelly-Moreno, Verified Chapters 1 - 72, Complete Newest Version.pdf
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Edition by Donnelly-Moreno, Verified Chapters 1 - 72, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Why invest into infodemic management in health emergenciesTina Purnat
A lecture discussing the challenge of health misinformation and information ecosystem in public health, how this impacts demand promotion in health, and how this then relates to responding to misinformation and infodemics in health emergencies. Appended with lots of tools, guidance and resources for people who want to do more reading.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Granulocyte antigens & antibodies and their role in transfusion medicinepptx
1. Granulocyte antigens & antibodies-
Their role in Transfusion Medicine
Presented By- Dr. Shiny
Moderator- Dr. Yadwinder Kaur
2. Granulocytes
•Granulocyte transfusion is required for neutropenic patients with infections not responding
to antibiotics.
•prepared either by pooling multiple units of buffy coat or by apheresis technology.
•Collection by apheresis technology involves donor stimulation with steroids or with G-CSF.
•The preparation of the final product requires a sedimentation agent such as HES to facilitate
the separation between red blood cells and granulocytes.
•Granulocytes must be irradiated and can be stored at 20-24ºC without agitation and used
within a maximum period of 24 hours.
3. •The separation between granulocyte and red blood cell layers is quite difficult, and
granulocyte collection is often contaminated with red blood cells. Hence the unit should
be ABO compatible with the recipient’s plasma.
•Microaggregate filters or leucocyte reduction filters are contraindicated while transfusing
granulocytes as they remove the collected.
•AABB Standards requires that 75% of granulocyte components contain at least 1 × 1010
granulocytes, although the optimal therapeutic dose in adult patients is unknown.
•For infants and children, a dose of 10 to 15 mL/kg may provide an adequate number of
granulocytes per dose.
4. Granulocyte Antigens
•Antibodies against granulocyte (neutrophil) antigens are implicated in the following
clinical syndromes:
neonatal alloimmune neutropenia (NAN)
Transfusion-related acute lung injury (TRALI)
immune neutropenia after HPC transplantation
refractoriness to granulocyte transfusion
chronic benign autoimmune neutropenia of infancy (AIN)
5. •To date, nine neutrophil antigens carried on five different glycoproteins have been
characterized and given human neutrophil alloantigen (HNA) designations by the
Granulocyte Antigen Working Party of the ISBT.
•This nomenclature system follows a similar convention to that used for HPA
nomenclature.
•Several of the antigens on granulocytes are shared with other cells and are not
granulocyte specific.
6. Antigens on FcyRIIIb (CD16b)
•FcyRIIIb (CD16b) is a GP linked protein receptor for the Fc of IgG and is present only
on the surfaces of neutrophils.
•Neutrophils express 100,000 to 200,000 molecules of CD16b.
•The first granulocyte-specific antigen detected was NA1, later named “HNA-1a.”
•3 alleles of HNA-1 have now been identified—HNA-1a, HNA-1b, and HNA-1c
•There are rare individuals (aprx 0.1%) whose neutrophils express no FcyRIIIb (CD16
null) and who can produce antibodies that are reactive with FcyRIIIb when they are
exposed to it through transfusion or pregnancy.
• Antibodies to HNA-1a and -1b have been implicated inTRALI, NAN, and AIN.
7. Antigens on CD177
•Neutrophils from approximately 3% to 5% of people lack expression of CD177 on
neutrophils.
•Lack of CD177 is thought to be caused by a Mrna splicing defect.
•CD177 is expressed only on neutrophils and belongs to the Ly-6/uPAR/snake-toxin
family of proteins.
•A recent report documented cation-dependent heterophilic interactions between
CD177 and the endothelial cell membrane protein PECAM-1(CD31), suggesting a
role for CD177 in neutrophil transendothelial migration to sites of infection.
•Antibodies against HNA-2 have been implicated in NAN, TRALI, and neutropenia
in marrow transplant recipients.
8. Antigens on CTL2
•HNA-3a and HNA-3b are carried on the choline transporter-like protein 2 (CTL2), and a
SNP in the gene (SLC44A2) accounts for the polymorphism.
•CTL2 is also expressed on both T and B lymphocytes, and small amounts are present on
platelets. .
•HNA- 3a antibodies occasionally develop in women after pregnancy, and they are the
most frequent cause of fatal TRALI.
•HNA-3b antibodies are rarely detected, but several have been found during screening of
the serum of multiparous blood donors.
9. Antigens on CD11a and CD11b
•HNA-4a and HNA-5a, both high-prevalence antigens, are present on monocytes and
lymphocytes as well as granulocytes.
•HNA-4a is carried on the CD11b.
•CD11b/18 plays a role in neutrophil adhesion to endothelial cells and phagocytosis of
C3bi opsonized microbes.
•There is some evidence showing that alloantibodies against HNA-4a interfere with
CD11b/ 18-dependent neutrophil adhesion and enhance neutrophil respiratory burst.
• Antibodies against HNA-4a have been implicated in NAN, and autoantibodies against
CD11b/18 have also been described.
10. •HNA-5a is carried on CD11a/18 glycoprotein.
•CD11a/18, like CD11b/18, plays a role in neutrophil adhesion to endothelial cells.
•Antibodies that are reactive with HNA-5a have been found in a chronically transfused
patient with aplastic anemia and have also been reported to be associated with NAN.
•The patient who made the original HNA-5a antibody experienced prolonged survival of
an HLA nonidentical skin graft that was attributed to the HNA-5a antibody.
11. Other Neutrophil Antigens
Neutrophils do not express ABH or other red cell group antigens, but they do express
modest amounts of Class I and II HLA only upon activation.
15. Neonatal Alloimmune Neutropenia
•NAN is caused by maternal antibodies against antigens on fetal neutrophils; the most
frequent specificities are against HNA-1a, HNA- 1b, and HNA-1c antigens.
•NAN may also occur in the children of women who lack the FcyRIIIb protein.
•Neutropenia in NAN can occasionally be life-threatening because of increased
susceptibility to infection.
•Management with antibiotics, IVIG, granulocyte colony-stimulating growth factor,
and/or plasma exchange may be helpful.
16. TRALI
•In TRALI, the causative antibodies are most often found in the plasma of the blood
donor. When these antibodies are transfused, they cause activation of primed neutrophils
that are sequestered in the lungs of certain patients.
•The activated neutrophils undergo oxidative burst releasing toxic substances that damage
pulmonary endothelium and resulting in capillary leak and pulmonary edema.
•Class I and II HLA and HNA antibodies have all been implicated in TRALI.
17. Autoimmune Neutropenia
•Autoimmune neutropenia may occur in adults or in infants. When present in adults, it
may be idiopathic or secondary to such diseases as rheumatoid arthritis or systemic
lupus erythematosus or to bacterial infections.
•In autoimmune neutropenia of infancy, usually occurring in children between the ages of
6 months and 2 years, the autoantibody has neutrophil antigen specificity (usually
HNA-1a or -1b) in about 30% of the patients.
•The condition is generally self-limiting, with recovery usually occurring in 7 to 24
months, and is relatively benign and manageable with antibiotics.
18. Testing for Granulocyte Antibodies and
antigens
•Granulocyte antibody testing is technically complex and labor intensive.
•The inability to maintain the integrity of granulocytes for testing that are stored at room
temperature, in refrigerated conditions, or by cryopreservation requires that cells should
be isolated from fresh blood on each day of testing.
•Class I HLA antibodies that are often present in patient sera complicate detection and
identification of granulocyte antibodies. For these reasons, it is critical that granulocyte
antibody and antigen testing be performed by an experience laboratory using appropriate
controls.
19. GRANULOCYTE AGGLUTINATION TEST
•This was one of the first tests developed for the detection of granulocyte antibodies.
•It is typically performed by overnight incubation of small volumes of isolated fresh
neutrophils with the patient’s serum in a microplate.
•The wells are viewed under an inverted phase microscope for neutrophil agglutination or
aggregation.
20.
21. GRANULOCYTE IMMUNOFLUORESCENCE
test
• This test also requires fresh target cells that are incubated, usually at room temperature
temperature for 30 minutes, and washed in EDTA and phosphate-buffered saline.
•Neutrophil-bound antibodies are then detected with fluorescein isothiocyanate-labeled
antihuman IgG or IgM with either a fluorescence microscope or a flow cytometer.
•A combination of agglutination and immunofluorescence tests is beneficial.
•Other methods include chemiluminescence, SPRCA, and the monoclonal antibody
immobilization of granulocyte antigens (MAIGA) assay, etc.
•The MAIGA assay is used to differentiate between HLA- and HNA-specific antibodies.
22.
23. HNA TYPING
•As with HPA, typing for HNA is largely performed using molecular methods to detect
the allelic variants that determine the antigens.
•Any methods used in HPA typing can be applied to HNA typing with simple
modifications to the primer and probe sequences.
•Readers are referred to several publications on this subject. Because the splicing defect
that results in CD177 deficiency is not known, typing for HPA-2/CD177 requires testing
for CD177 on freshly isolated neutrophils using specific monoclonal antibodies and the
granulocyte immuno fluorescence test.
24. Mixed passive agglutination:
Sera to be tested are incubated with neutrophil extract in wells of U-bottom Terasaki plates.
Antibody binding is detected using sheep erythrocytes coated with antihuman IgG.
The assay has been shown to detect antibodies specific for HNA-1a, -1b, -2a and -3a.
25. Monoclonal-antibody capture
assays:
•The monoclonal-antibody capture, or monoclonal-antibody immobilization of
granulocyte antigens (MAIGA) assay, allows the detection of antibodies to specific
neutrophil membrane glycoproteins.
•It can be used to detect antibodies to FcγRIIIb (CD16), NB1 gp (CD177), leucocyte
function antigen-1 (LFA-1 or CD11a) and complement component C3bi receptor (CR3 or
CD11b).
•In addition, this assay detects antibodies to HNA- 1, -2, -4 and -5. The assay allows
recognition of antibodies to specific neutrophil glycoproteins even when antibodies to
HLA antigens are present.